Ligand validation:6S2B

NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6S2B_NAG_B_601	86%	51%	0.083	0.952	0.55	1.32	-	3	0	0	100%	1
6S2B_NAG_A_605	53%	47%	0.109	0.869	0.68	1.36	-	3	0	0	100%	1
6S2B_NAG_A_601	47%	59%	0.16	0.898	0.52	1.04	-	-	0	0	100%	1
6S2B_NAG_A_607	42%	51%	0.168	0.885	0.55	1.31	-	1	0	0	100%	1
6S2B_NAG_B_605	25%	54%	0.195	0.83	0.48	1.28	-	2	0	0	100%	1
6S2B_NAG_A_606	20%	52%	0.242	0.847	0.49	1.34	-	2	0	0	100%	1
6S2B_NAG_B_606	12%	58%	0.293	0.829	0.58	1.03	-	-	0	0	100%	1
6S2B_NAG_B_604	9%	50%	0.298	0.789	0.58	1.34	-	2	0	0	100%	1
6S1T_NAG_B_602	78%	66%	0.098	0.94	0.48	0.83	-	1	0	0	100%	1
3U75_NAG_C_1394	55%	32%	0.133	0.901	0.59	2.08	-	5	0	0	100%	1
3U14_NAG_B_1219	54%	8%	0.151	0.914	1.74	2.78	2	6	0	0	100%	1
3KF3_NAG_A_3001	47%	56%	0.128	0.865	0.57	1.11	-	1	0	0	100%	1
3KF5_NAG_A_4001	44%	43%	0.185	0.913	0.45	1.71	-	4	1	0	100%	1
3H0C_NAG_A_794	100%	56%	0.021	0.995	0.61	1.08	-	1	0	0	100%	1
5F9W_NAG_A_510	100%	88%	0.023	0.994	0.24	0.43	-	-	0	0	100%	1
5LDS_NAG_B_1007	100%	67%	0.022	0.995	0.48	0.79	-	-	0	0	100%	1
5O5D_NAG_A_601	100%	65%	0.022	0.994	0.32	0.99	-	1	0	0	100%	1
6MUG_NAG_G_629	100%	76%	0.022	0.994	0.35	0.58	-	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.